Idraparinux was noninferior to standard therapy for deep venous thrombosis but inferior for pulmonary embolism

Affiliations

Comment

Scott C Woller et al. ACP J Club. 2008 Jan-Feb.

. 2008 Jan-Feb;148(1):19-20.

¹ Intermountain Medical Center and University of Utah School of Medicine, Salt Lake City, Utah, USA.

No abstract available

Comment on

Idraparinux versus standard therapy for venous thromboembolic disease.
van Gogh Investigators; Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE. van Gogh Investigators, et al. N Engl J Med. 2007 Sep 13;357(11):1094-104. doi: 10.1056/NEJMoa064247. N Engl J Med. 2007. PMID: 17855670 Clinical Trial.